Bone Biologics Corp (BBLGW) Capital Expenditures (2015)
Bone Biologics (BBLGW) posted quarterly Capital Expenditures of $504.0 for Q1 2015.
Bone Biologics Corp (BBLGW) Capital Expenditures (2015) Analysis & Trends
Bone Biologics (BBLGW) has reported Capital Expenditures for 1 consecutive years, with $504.0 the latest figure, recorded in Q1 2015.
- In Q1 2015, Capital Expenditures changed N/A year-over-year to $504.0; the TTM figure through Dec 2015 stood at $504.0 (changed N/A YoY), while the FY2015 annual figure was $504.0, down 95.77% from the prior year.
- Capital Expenditures was little changed at $504.0 in Q1 2015 per BBLGW's latest filing.
- Across five years, Capital Expenditures topped out at $504.0 in Q1 2015 and bottomed at $504.0 in Q1 2015.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 504.00 |
| Mar 31, 2015 | 504.00 |